Brannelly Paul 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Jan 29, 2019
Insider Transaction Report
Form 4
Brannelly Paul
Exec VP & CFO
Transactions
- Award
Stock Option (Right to Purchase)
2019-01-25+32,000→ 32,000 totalExercise: $15.90Exp: 2029-01-25→ Common Stock (32,000 underlying) - Award
Common Stock
2019-01-25+32,000→ 154,981 total
Footnotes (2)
- [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2020, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
- [F2]Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2020, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.